Registration Open


AWWAL Share Price | Awwal Modaraba

AWWAL Share Price History

AWWAL (Awwal Modaraba) listed in PSX,ALLSHR. AWWAL share price / stock price today is 10.00 PKR. Today volume traded in AWWAL is 500, price change is 0.00%, high price is 10.00 PKR, and low price is 10.00 PKR.

AWWAL Performance
Return (%) Absolute Return
1 Week 1 Month 3 Month 6 Month 1 Year
Return 0% 0% 0% 0% 0%

Company Snapshot

loading
AWWAL
2023-04-05 13:31:12
Current
10.00
Change
0.00
Change %
0.00%
Volume
500.00
Price to Earnings Ratio
15.38
Earning per Share
0.65
Book Value
11.98
Price to Book
0.83
Market Cap
0
Dividend
0.22
Dividend Yield (%)
2.20 %
Debt to Equity
0.00
Net Profit Margin
0.00 %
Gross Profit Margin
0.00 %
Current Ratio
17.65
Face Value
Shares
0
FreeFloat
0
Free Float %
0.00
Equity to Asset(%)
97.51
Interest
0.00
Beta
Upper/Lower Cap
11.00 / 9.00
Times-Revenue Method New
52 Week High
10.00
52 Week Low
10.00
High
10.00
Low
10.00
Previous
10.00
Company Financials
Company Announcements
Date Announce Title Attachments
2023-06-27 Delisting of Awwal Modaraba View PDF
2023-06-06 DISCLOSURE OF MATERIAL INFORMATION View PDF
2023-06-01 NOTICE -FINAL BOOK CLOSURE PURSUANT - MERGER OF AWWAL MODARABA View PDF
2023-04-28 Transmission of Quarterly Report for the Period Ended March 31, 2023 View PDF
2023-04-28 Financial Results for the Quarter Ended March 31, 2023 View PDF
2023-04-19 Board Meeting View PDF
2023-03-17 Material Information View PDF
2023-03-01 Transmission of Quarterly Report for the Period Ended December 31, 2022 View PDF
2023-03-01 Financial Results for the Quarter Ended December 31, 2022 View PDF
2023-02-28 Board Meeting In Progress View PDF
2023-02-21 Board Meeting View PDF
2022-12-12 CORPORATE BRIEFING SESSION ZOOM LINK AND PRESENTATION View PDF
2022-12-05 CORPORATE BRIEFING SESSION View PDF
2022-12-01 Credit of Final Cash Dividend View PDF
2022-11-01 Approval of Extension in Time for Holding the Annual Review Meeting for the Year Ended 30-06-2022 View PDF
2022-10-28 Financial Results for the Quarter Ended September 30, 2022 View PDF
2022-10-28 Transmission of Quarterly Report for the Period Ended September 30, 2022 View PDF
2022-10-25 Notice of Annual Review Meeting- 2022 View PDF
2022-10-25 Transmission of Annual Report for the Year Ended June 30, 2022 View PDF
2022-10-21 Board Meeting View PDF
2022-10-21 Financial Results for the Year Ended 30-06-2022 View PDF
2022-10-20 Board Meeting in Progress View PDF
2022-10-13 Board Meeting View PDF
2022-09-30 Applied for Extension for Holding ARM for the Year Ended June 30, 2022 View PDF
2022-06-09 Material Information View PDF
2022-05-18 Notice of Extraordinary General Meeting View PDF
2022-04-28 Transmission of Quarterly Report for the Period ended March 31, 2022 View PDF
2022-04-25 Material Information View PDF
2022-04-04 Material Information View PDF
2022-03-11 Material Information View PDF
2022-03-09 Emergent Board Meeting Other Than Financial Results View PDF
2022-02-28 Transmission of Quarterly Report for the Half Year ended December 31, 2021 View PDF
2022-02-22 Financial Results for the Quarter & Half Year ended December 31, 2021 View PDF
2022-02-15 Board Meeting View PDF
2022-01-11 CORPORATE BRIEFING SESSION View PDF
2021-11-25 Material Information View PDF
2021-11-22 Emergent Meeting of Board of Directors View PDF
2021-11-22 Material Information View PDF
2021-10-29 Transmission of Quarterly Report for the Quarter ended 30 September, 2021 View PDF
2021-10-29 Credit of Final Cash Dividend View PDF
2021-10-26 Material Information View PDF
2021-10-26 Financial Results for the Quarter Ended 30 September, 2021 View PDF
2021-10-15 Board Meeting View PDF
2021-09-22 Notice of Annual Review Meeting for the year ended June 30, 2021 View PDF
2021-09-22 Transmission of Annual Report for the year ended June 30, 2021 View PDF
2021-08-27 Financial Results for the Year ended June 30, 2021 View PDF
2021-08-20 Board Meeting View PDF
2021-06-28 Material information-Amendment in the Prospectus of Modaraba-REVISED CLAUSES View PDF
2021-06-25 CORPORATE BRIEFING SESSION View PDF
2021-06-23 Material information-Amendment in the Prospectus of Modaraba View PDF
2021-05-03 Re-appointment of Chief Executive Officer View PDF
2021-05-03 Transmission of Quarterly Report for the Qaurter ended March 31 2021 View PDF
2021-04-30 Financial Results for the Quarter ended March 31, 2021 View PDF
2021-04-22 Board Meeting View PDF
2021-04-19 Change of Registered Office Address View PDF
2021-02-26 Transmission of Quarterly Report for the Period Ended December 31, 2020 View PDF
2021-02-23 Financial Results for the Quarter and Half Year ended December 31, 2020 View PDF
2021-02-15 Board Meeting PDF

About Company

Awwal Modaraba has been floated under the Modaraba Companies and Modaraba (Floatation and Control) Ordinance, 1980. The Modaraba is managed by the Awwal Modaraba Management Limited. It is a perpetual, multi purpose and multi dimensional Modaraba and is primarily engaged in providing Working Capital, Term Finance, Ijarah, Musharika, Morabaha and other Shari'ah compliant investment/instrument to credit worthy customers.

Address
3rd Floor, Horizon Vista ,Plot Commercial No.10 , Block No.4 Clifton Karachi
Website
www.awwal.com.pk
Key People
Mr. Karim Hatim CEO
Mr. Khalid Aziz Mirza Chairman
Ms. Misbah Asjad Company Secretary

Page description

AWWAL (Awwal Modaraba) listed in PSX,ALLSHR. AWWAL Share Price / Stock Price is 10.00 PKR. You can also check; Share Price History, AWWALPayouts, Annoucements, Snapshot, Company details, Fundamentals, Technicals and much more.

AWWAL Share Price AWWAL Stock Price Awwal Modaraba psx stock kse100 stock AWWAL Stock Price ALLSHR Share price History AWWAL Payouts Annoucements Snapshot AWWAL Address AWWAL CEO Book Value Price/Book Ratio Dividend Yield Earning Per Share Net Profit Margin Gross Profit Margin Price to Sales Ratio Long Term Debt to Equity Interest Cover (Times) Equity to Assets (%) Current Ratio (Times) Cash Payout Ratio Technical Indicators Moving Averages AWWAL Chairperson AWWAL Secretary AWWAL Website About AWWAL

My Watchlist

Not logged in, please login to view watchlist!

Today's Market Performers KSE100

Change
loading

Financial literacy is your key to success and a promise of a secure future in turbulent times. We offer you the right education and resources you need to achieve your financial dreams. Sarmaaya is a trusted source of research and information about Forex, Mutual Funds, and Stocks. Our widgets, tools and calculators aid in identifying potential investment opportunities and valuable insights that can help achieve your short and long-term financial goals.

© 2024 SARMAAYA.PK

Sarmaaya Financials Private Limited is a Pakistan Stock Exchange (PSX) authorized data redistributor. Sarmaaya & CS Solutions (Pvt.) Limited (CS) do not guarantee the timeliness, accurateness, or completeness of any data or information on the website. Sarmaaya & CS makes no warranties, express or implied, as to Sarmaaya & CS or any data or values relating thereto or results to be obtained therefrom, and expressly disclaims all warranties of merchantability and fitness for a particular purpose with respect thereto. To the maximum extent allowed by law, Sarmaaya & CS, its licensors, and their respective employees, contractors, agents, suppliers and vendors shall have no liability or responsibility whatsoever for any injury or damages – whether direct, indirect, consequential, incidental, punitive or otherwise – arising in connection with Sarmaaya & CS or any data or values relating thereto – whether arising from their negligence or otherwise. Nothing in the website shall constitute or be construed as an offering of financial instruments or as investment advice or investment recommendations (i.e., recommendations as to whether or not to “buy”, “sell”, “hold”, or to enter or not to enter into any other transaction involving any specific interest or interests) by Sarmaaya & CS or a recommendation as to an investment or other strategy by Sarmaaya & CS. Data and other information available via the website should not be considered as information sufficient upon which to base an investment decision.